Stock Forecast
As of Thu Dec 31 2020 00:00:02 GMT+0000 (Coordinated Universal Time) shares of JNCE Jounce Therapeutics 4.06 percentage change in price since the previous day's close. Around 0 of 39851000 changed hand on the market. The Stock opened at 6.32 with high and low of 6.32 and 6.75 respectively. The price/earnings ratio is: - and earning per share is -3.01. The stock quoted a 52 week high and low of 2.85 and 11.72 respectively.
BOSTON (AI Forecast Terminal) Thu, Dec 31, '20 AI Forecast today took the forecast actions: In the context of stock price realization of JNCE Jounce Therapeutics is a decision making process between multiple investors each of which controls a subset of design variables and seeks to minimize its cost function subject to future forecast constraints. That is, investors act like players in a game; they cooperate to achieve a set of overall goals.Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. Machine Learning based technical analysis (n+15) for JNCE Jounce Therapeutics as below:
JNCE Jounce Therapeutics Credit Rating Overview
We rerate JNCE Jounce Therapeutics because of derivatives receivables represent more than 0.5% of total assets for entities reporting under U.S. GAAP. We use econometric methods for period (n+15) simulate with Commodity Channel Index Factor. Reference code is: 2056. Beta DRL value REG 42 Rational Demand Factor LD 5114.1888. In addition, a speculative-grade company's access to the credit markets during times of stress, such as the financial crisis, is often a function of the capital market's appetite for risk. Accordingly, it would be rare that we would characterize a speculative-grade company as having a generally high standing in the credit markets, and even low-investment-grade companies may not have access to a diversity of funding sources required for this assessment. Credit Rating AI Process rely on primary sources of information: Sec Filings, Financial Statements, Credit Ratings, Semantic Signals. Take a look at Machine Learning section for Financial Deep Reinforcement Learning.
Oscillators are used for generating credit risk signals by using the semantic and financial signals. The value of the oscillators indicate the strength of trend. Using the correlation matrices, the risk map for JNCE Jounce Therapeutics as below:
Frequently Asked Questions
Q: What is JNCE Jounce Therapeutics stock symbol?A: JNCE Jounce Therapeutics stock referred as NASDAQ:JNCE
Q: What is JNCE Jounce Therapeutics stock price?
A: On share of JNCE Jounce Therapeutics stock can currently be purchased for approximately 6.67
Q: Do analysts recommend investors buy shares of JNCE Jounce Therapeutics ?
A: Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. View Machine Learning based technical analysis for JNCE Jounce Therapeutics at daily forecast section
Q: What is the earning per share of JNCE Jounce Therapeutics ?
A: The earning per share of JNCE Jounce Therapeutics is -3.01
Q: What is the market capitalization of JNCE Jounce Therapeutics ?
A: The market capitalization of JNCE Jounce Therapeutics is 265806173
